Projects include developing a new technique that may restore sensory loss after injury; developing new, noninvasive brain stimulation technique to treat neurological disorders, including pain, traumatic brain injury, epilepsy, stroke, Parkinson’s disease and Alzheimer’s disease; successfully reprogramming glial cells in the central nervous system into new neurons that promote recovery after spinal cord injury and revealing an untapped potential to leverage these cell for regenerative medicine.
Clinicians work in concert with investigators at the Indiana Spinal Cord and Brain Injury Research Group (ISCBIRG), an integrated component of Stark Neurosciences Research Institute. The group is comprised of a critical mass of key principal investigators who study the molecular mechanisms underlying spinal cord injury and traumatic brain injury. They work to develop novel repair strategies to promote neural reorganization and functional recovery in experimental models of these injuries. The long-term goal of these studies is to translate promising treatments from animal models to humans.
Faculty investigators also lead more than 20 clinical trials that specialize in neurosurgical clinical research of various disease states, such as hydrocephalus, epilepsy, cancers of the brain, traumatic brain injury and brain aneurysms. Many of these trials are conducted in collaboration with research institutions across the country.